Qualtrics International Inc.
(XM)
Monteverde & Associates Announces the Investigation of Qualtrics International Inc.
Provention Bio, Inc.
(PRVB)
Monteverde & Associates Announces the Investigation of Provention Bio, Inc.
Kimball International, Inc.
(KBAL)
Monteverde & Associates Announces the Investigation of Kimball International, Inc.
Diversey Holdings, Ltd.
(DSEY)
Monteverde & Associates Announces the Investigation of Diversey Holdings, Ltd.
Radius Global Infrastructure, Inc.
(RADI)
Monteverde & Associates Announces the Investigation of Radius Global Infrastructure, Inc.
TCR² Therapeutics Inc.
(TCRR)
Monteverde & Associates Announces the Investigation of TCR² Therapeutics Inc.
Adaptimmune Therapeutics plc
(ADAP)
Monteverde & Associates Announces the Investigation of Adaptimmune Therapeutics plc
Ranger Oil Corp.
(ROCC)
Monteverde & Associates Announces the Investigation of Ranger Oil Corp.
Adamis Pharmaceuticals Corp.
(ADMP)
Monteverde & Associates Announces the Investigation of Adamis Pharmaceuticals Corp.
Jounce Therapeutics, Inc.
(JNCE)
Monteverde & Associates Announces the Investigation of Jounce Therapeutics, Inc.
Broadmark Realty Capital Inc.
(BRMK)
Monteverde & Associates Announces the Investigation of Broadmark Realty Capital Inc.
Focus Financial Partners Inc.
(FOCS)
Monteverde & Associates Announces the Investigation of Focus Financial Partners Inc.
Vascular Biogenics Ltd.
(VBLT)
Monteverde & Associates Announces the Investigation of Vascular Biogenics Ltd.
Horizon Technology Finance Management LLC
(HRZN)
Monteverde & Associates Announces the Investigation of Horizon Technology Finance Management LLC
Infinity Pharmaceuticals, Inc.
(INFI)
Monteverde & Associates Announces the Investigation of Infinity Pharmaceuticals, Inc.
